undamentalytics Newsletter

Koski Robert C: insider trades

Director at 2 companies we cover. 3 open-market purchases and 32 sales not made under a pre-set plan, reported from March 15, 2010 to December 16, 2022.

Would copying Koski Robert C’s purchases have beaten the S&P 500?

Too few purchases to judge. None of their purchases has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. After their sales, the shares moved +11.2% against the index over 12 months on average (a negative figure means selling was the right call); 43% trailed it. None of their purchases could be priced, so there is no copy portfolio.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Koski Robert C: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 28 +4.7% +4.0% 43% 9 0.92 0.38 No reliable evidence
Sales, 12 months after the report 28 +11.2% +8.2% 43% 9 −0.03 0.98 No reliable evidence
Sales, 12 months after the trade 28 +10.5% +6.4% 43% 9 −0.13 0.90 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Helios Technologies, Inc. HLIO —028March 15, 2010June 26, 2019
Oragenics Inc OGEN —34December 2, 2014December 16, 2022

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
December 16, 2022December 14, 2022 OGEN Sale $29,789 not yetnot yetnot yet
December 1, 2022November 29, 2022 OGEN Sale $76,000 not yetnot yetnot yet
January 3, 2022December 30, 2021 OGEN Purchase $465,982 not yetnot yetnot yet
December 23, 2020December 22, 2020 OGEN Sale $133,300 not yetnot yetnot yet
December 31, 2019December 27, 2019 OGEN Sale $105,000 not yetnot yetnot yet
June 26, 2019June 24, 2019 HLIO Sale $114,300 −12.4%−22.9%−26.2%
June 25, 2019June 21, 2019 HLIO Sale $235,150 −7.7%−22.5%−29.7%
September 12, 2018September 10, 2018 HLIO Sale $1,152,250 −19.7%−22.1%−17.8%
June 15, 2018May 21, 2018 HLIO Sale $494,916 +3.8%−14.9%−21.4%
August 16, 2017August 14, 2017 HLIO Sale $777,892 +19.8%−15.5%−15.9%
August 29, 2016August 25, 2016 HLIO Sale $576,270 +25.5%+38.8%+38.0%
August 24, 2016August 22, 2016 HLIO Sale $988,225 +26.3%+38.0%+40.9%
July 1, 2016June 30, 2016 HLIO Sale $370,631 +4.3%+24.3%+27.4%
June 23, 2016June 22, 2016 HLIO Sale $308,500 −1.2%+26.6%+17.5%
March 22, 2016March 18, 2016 HLIO Sale $176,562 −8.3%−6.6%−10.9%
December 16, 2014December 12, 2014 OGEN Purchase $15,100 not yetnot yetnot yet
December 2, 2014November 28, 2014 OGEN Purchase $13,965 not yetnot yetnot yet
November 10, 2014November 6, 2014 HLIO Sale $1,751,230 −12.2%−31.2%−32.8%
March 27, 2014March 25, 2014 HLIO Sale $132,357 −8.9%−12.1%−17.3%
November 21, 2013November 19, 2013 HLIO Sale $542,620 −0.1%−14.3%−12.3%
September 18, 2013September 16, 2013 HLIO Sale $1,566,050 +6.3%−6.0%−7.1%
June 26, 2013June 25, 2013 HLIO Sale $175,188 +7.6%+6.0%+4.7%
December 21, 2012December 20, 2012 HLIO Sale $765,039 +14.8%+28.6%+23.3%
December 3, 2012November 29, 2012 HLIO Sale $290,350 +8.8%+24.0%+33.3%
September 13, 2012September 11, 2012 HLIO Sale $50,500 −1.8%+11.8%+15.6%
September 11, 2012September 7, 2012 HLIO Sale $24,800 +1.7%+16.5%+19.0%
March 19, 2012March 15, 2012 HLIO Sale $216,408 −13.0%+3.4%+0.1%
March 21, 2011March 17, 2011 HLIO Sale $219,260 +9.5%−6.1%−2.1%
March 21, 2011March 17, 2011 HLIO Sale $110,274 +9.5%−6.1%−2.1%
October 1, 2010October 1, 2010 HLIO Sale $103,955 +30.5%+10.4%+8.1%
October 1, 2010September 30, 2010 HLIO Sale $388,313 +30.5%+10.4%+23.1%
June 29, 2010June 28, 2010 HLIO Sale $348,354 +11.4%+78.4%+70.0%
June 29, 2010June 28, 2010 HLIO Sale $25,336 +11.4%+78.4%+70.0%
May 27, 2010May 26, 2010 HLIO Sale $461,784 −3.4%+63.4%+59.9%
March 15, 2010March 11, 2010 HLIO Sale $284,161 −1.0%+35.0%+37.4%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Koski Robert C traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.